Remedent Stock

Remedent Net Margin

The Net Profit Margin of Remedent (REMI) as of Jul 27, 2026 is -27.83 %. In the previous year, Net Profit Margin was -173.05 % — a change of -83.92% (higher).

Net Margin

-27.83 %

YoY

-83.92%

Last updated:

Net Profit Margin of Remedent is 2026 -27.83 % . Net Profit Margin of Remedent was 2025 -173.05 % . It decreases by -83.92% higher compared to the previous year.

Remedent's net margin stands at -27.8%, up from -80.3% several years earlier.

Access this data via the Eulerpool API

Remedent Stock analysis

What does Remedent do? Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remedent stock

Net Profit Margin of Remedent is -27.83 % in 2026.

Access this data via the Eulerpool API

Margins — Remedent

All Key Metrics — Remedent